First National Bank Of South Miami Clovis Oncology, Inc. Transaction History

First National Bank Of South Miami

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $413 - $641	-100 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.63 - $32.67 $1,163 - $3,267	100 New	100 $3,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of First National Bank Of South Miami, based on Form 13F filings with the SEC.

Stay updated on First National Bank Of South Miami with notifications on news.